TGFBR1 and Myocardial fibrosis: These findings demonstrate the protective effect of α1-AR blockage against LPS-mediated myocardial fibrosis, which is achieved by directly inhibiting the PKC-p38-Smad2/3 signaling pathway and promoting TGF-BR1 downregulation through restoring CHIP expression.